195 related articles for article (PubMed ID: 10023342)
1. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
3. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
Sasaki K; Niitsu N
Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
[TBL] [Abstract][Full Text] [Related]
6. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.
Yakushijin Y; Steckel J; Kharbanda S; Hasserjian R; Neuberg D; Jiang W; Anderson I; Shipp MA
Blood; 1998 Jun; 91(11):4282-91. PubMed ID: 9596677
[TBL] [Abstract][Full Text] [Related]
7. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
Stauder R; Eisterer W; Thaler J; Günthert U
Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
[TBL] [Abstract][Full Text] [Related]
9. CD44 variant expression in cutaneous T-cell lymphoma.
Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ
J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
11. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
12. CD44 variant exons in leukemia and lymphoma.
Akisik E; Bavbek S; Dalay N
Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
[TBL] [Abstract][Full Text] [Related]
14. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K
J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
[TBL] [Abstract][Full Text] [Related]
16. CD44 and the adhesion of neoplastic cells.
Rudzki Z; Jothy S
Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
[TBL] [Abstract][Full Text] [Related]
17. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
19. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
